- CRDF Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Cardiff Oncology (CRDF) S-3Shelf registration
Filed: 14 Feb 19, 5:26pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Trovagene, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated February 26, 2018, except for the effects of the reverse stock split discussed in Note 15 to the consolidated financial statements, as to which the date is June 4, 2018, relating to the consolidated financial statements of Trovagene, Inc. (the “Company”) appearing in the Company’s Registration Statement on FormS-1 (FileNo. 333-224808) for the year ended December 31, 2017. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP |
San Diego, California |
February 14, 2019 |